A detailed history of Darwin Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Darwin Advisors, LLC holds 16 shares of UTHR stock, worth $5,753. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Holding current value
$5,753
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$311.04 - $363.55 $4,976 - $5,816
16 New
16 $5,000
Q2 2020

Aug 06, 2020

SELL
$92.74 - $125.82 $1,483 - $2,013
-16 Closed
0 $0
Q1 2020

May 01, 2020

BUY
$79.39 - $115.35 $1,270 - $1,845
16 New
16 $1,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.